🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The safety and tolerability of MK-8591A, a 2-drug fixed dose combination (F...
Status
Active Not Recruiting
Location
Pueblo Family Physicians ( Site 0010)
Start Date
2021-09-15
Trial ID
NCT04776252
Treatments Being Tested
The goal of this clinical study is to provide continued access to the study...
Status
Recruiting
Location
Helios Salud
Start Date
2024-08-27
Trial ID
NCT06337032
Treatments Being Tested
This study was evaluate the effect of elexacaftor (ELX)/tezacaftor (TEZ)/iv...
Status
Completed
Location
Royal Adelaide Hospital
Start Date
2021-01-15
Trial ID
NCT04599465
Treatments Being Tested
The primary objectives of this study are to evaluate the antiviral efficacy...
Status
Completed
Location
Seoul National University Bundang Hospital
Start Date
2020-01-03
Trial ID
NCT04211909
Treatments Being Tested
This study was carried out in the Clinical and Analytical Unit of the Pharm...
Status
Completed
Location
Laboratorio Silanes, S.A. de C.V.
Start Date
2018-10-23
Trial ID
NCT05428306
The primary objectives of this study are to determine the antiviral efficac...
Status
Completed
Location
Multiple Locations
Start Date
2015-12-22
Trial ID
NCT02613871
Treatments Being Tested
This study will assess the bioequivalence (BE) of Lesinurad/Allopurinol Fix...
Status
Completed
Location
Multiple Locations
Start Date
2016-08-30
Trial ID
NCT02888054
Treatments Being Tested
This is a randomized, multi-site, open-label trial of the co-administration...
Status
Completed
Location
Multiple Locations
Start Date
2016-01-05
Trial ID
NCT02601573
Treatments Being Tested
A randomized, open-label, single-dose, parallel-arm, Phase 1 study to inves...
Status
Completed
Location
Early Phase Clinical Unit;Klinikum Westend, Haus 31
Start Date
2017-12-18
Trial ID
NCT03286829
The primary purpose is to assess the effect of Daclatasvir (DCV)/Asunaprevi...
Status
Completed
Location
Multiple Locations
Start Date
2014-04
Trial ID
NCT02104843
Treatments Being Tested